Results 21 to 30 of about 539,825 (360)

Outcomes of Low-Grade Appendiceal Mucinous Neoplasms with Remote Acellular Mucinous Peritoneal Deposits [PDF]

Annals of Surgical Oncology, 2018
Campbell S. Roxburgh, Yaniv Fenig, Andrea Cercek, Jinru Shia, Rachel M. Rassam, Philip B. Paty, Garrett M. Nash   +6 more
openalex   +2 more sources

Efficacy and Insights from an Extensive Series of Cytoreductive Surgery for Peritoneal Neoplasms: A High-Volume Single-Center Experience. [PDF]

Cancers (Basel)
Aulicino M, Santullo F, D'Annibale G, Abatini C, Attalla El Halabieh M, Orsini C, Barberis L, D'Agostino L, Tersigni I, Pacelli F, Lodoli C, Di Giorgio A, Ferracci F, Pacelli F.   +13 more
europepmc   +2 more sources

Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis [PDF]

, 2016
Jason M. Foster, Richard Sleightholm, Steve Wahlmeier, Brian Loggie, Poonam Sharma, Asish Patel   +5 more
core   +3 more sources

Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms [PDF]

American Journal of Surgery, 2011
E. Nicole Parson, Samuel S. Lentz, Greg Russell, Perry Shen, Edward A. Levine, John H. Stewart   +5 more
openalex   +2 more sources

Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination. [PDF]

Ann Surg Oncol
Levine EA, Cos H, Votanopoulos KI, Shen P, Russell G, Mansfield P, Fournier K, Bartlett D, Stewart JH.   +8 more
europepmc   +2 more sources

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

Pleura and Peritoneum, 2023
There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes ...
Falla-Zuniga Luis Felipe, Sardi Armando, King Mary Caitlin, Lopez-Ramirez Felipe, Barakat Philipp, Nieroda Carol, Diaz-Montes Teresa, Gushchin Vadim   +7 more
doaj   +1 more source

A Systematic Review of Surgical Management Strategies in the Treatment of Peritoneal Carcinomatosis of Neuroendocrine Origin

Current Oncology, 2023
Cytoreductive surgery (CRS) represents the cornerstone of surgical management for peritoneal carcinomatosis (PC) and involves peritonectomy procedures aimed at complete peritoneal tumour resection.
Megan Fallows, Ambareesh Samant, Harry Wilson, Reza Mirnezami   +3 more
doaj   +1 more source

Value of Ascitic Lipids in the Differentiation between Cirrhotic and Malignant Ascites [PDF]

, 1986
Ascitic fluid concentrations of cholesterol, triglycerides and phospholipids, were compared with ascitic fluid total protein in 40 patients with chronic liver disease, 51patients with various neoplasms and 1 patient with cardiac failure.
Alexander L. Gerbes, Boyer, Dieter Jüngst, Eggstein, Eimermacher, Fiske, Galen, Greene, Gustav Paumgartner, Kirkeby, Nystrom, Paddock, Pare, Polak, Robert Martin, Rovelstad, Röschlau, Sampliner, Schölmerich, Suzuki, Svanberg, Takayama, Tomb   +22 more
core   +1 more source

Deep Convolutional Neural Network Based on Computed Tomography Images for the Preoperative Diagnosis of Occult Peritoneal Metastasis in Advanced Gastric Cancer

Frontiers in Oncology, 2020
We aimed to develop a deep convolutional neural network (DCNN) model based on computed tomography (CT) images for the preoperative diagnosis of occult peritoneal metastasis (OPM) in advanced gastric cancer (AGC).
Zixing Huang, Dan Liu, Xinzu Chen, Du He, Pengxin Yu, Baiyun Liu, Bing Wu, Jiankun Hu, Bin Song   +8 more
doaj   +1 more source

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

The Ewha Medical Journal, 2023
In stage IV colorectal cancer (CRC), peritoneal metastasis is associated with a poor prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) is an effective treatment option ...
Youngbae Jeon, Eun Jung Park
doaj   +1 more source